#161642

Anti-ZIP4 antibody

Please Enter Your Email ID
Email ID

Cat. #161642

Anti-ZIP4 antibody

Cat. #: 161642

Sub-type: Primary antibody

Target: Zinc Transporter ZIP4

Class: Monoclonal

Application: Western Blottting, Immunostaining

Reactivity: Human

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: RubĂŠn Vicente, Pilar Rivera

Institute: Universitat Pompeu Fabra

Primary Citation: Li et al. 2007. Proc Natl Acad Sci U S A. 104(47):18636-41. PMID 18003899.

Tool Details
Target Details
Applications
References

Tool Details

*FOR RESEARCH USE ONLY

  • Name: Anti-ZIP4 antibody
  • Cancer: Pancreatic cancer
  • Research fields: Cancer
  • Clone: 33
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Strain: Patent protected: EP20382172A¡2020-03-10, US 17/909,885. EP3878473A1, EP21709731A, EP2021056036W.
  • Reactivity: Human
  • Host: Mouse
  • Disease: Acrodermatitis enteropathica
  • Application: Western Blottting, Immunostaining
  • Description: Zinc transporter ZIP4 is a transmembrane protein which in humans is encoded by the SLC39A4 gene. ZIP4 is overexpressed in human pancreatic cancer and contributes to tumor progression by accumulation of intracellular zinc and stimulation of cell proliferation, endothelial mesenchymal transition and cancer progression.
  • Isotype: IgG

Target Details

  • Target: Zinc Transporter ZIP4
  • Target background: Zinc transporter ZIP4 is a transmembrane protein which in humans is encoded by the SLC39A4 gene. ZIP4 is overexpressed in human pancreatic cancer and contributes to tumor progression by accumulation of intracellular zinc and stimulation of cell proliferation, endothelial mesenchymal transition and cancer progression. Thus, overexpression of ZIP4 is considered a malignant factor for pancreatic cancer progression.

Applications

  • Application: Western Blottting, Immunostaining

References

  • Li et al. 2007. Proc Natl Acad Sci U S A. 104(47):18636-41. PMID 18003899.